Literature DB >> 27989507

Corrigendum to "Profile of Silodosin" [Eur Urol Suppl 2010;9:491-5].

Francesco Montorsi1.   

Abstract

Year:  2010        PMID： 27989507     DOI： 10.1016/j.eururo.2010.11.014

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  5 in total

Review 1.  Efficacy and safety of silodosin in the medical expulsion therapy for distal ureteral calculi: a systematic review and meta-analysis.

Authors:  Wei Huang; Peng Xue; Huantao Zong; Yong Zhang
Journal:  Br J Clin Pharmacol       Date:  2015-09-21       Impact factor: 4.335

Review 2.  Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement.

Authors:  Giacomo Novara; Andrea Tubaro; Roberto Sanseverino; Sebastiano Spatafora; Walter Artibani; Filiberto Zattoni; Francesco Montorsi; Christopher R Chapple
Journal:  World J Urol       Date:  2012-09-28       Impact factor: 4.226

Review 3.  The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia with α-blockers: focus on silodosin.

Authors:  Júlio Fonseca; Carlos Martins da Silva
Journal:  Clin Drug Investig       Date:  2015-02       Impact factor: 2.859

Review 4.  The efficacy and safety of silodosin for the treatment of ureteral stones: a systematic review and meta-analysis.

Authors:  Diandong Yang; Jitao Wu; Hejia Yuan; Yuanshan Cui
Journal:  BMC Urol       Date:  2016-05-27       Impact factor: 2.264

5.  Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications.

Authors:  Giulia Rivasi; Martina Rafanelli; Enrico Mossello; Michele Brignole; Andrea Ungar
Journal:  Drugs Aging       Date:  2020-10       Impact factor: 3.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.